ESTIMATION OF HOSPITAL COST SAVINGS ASSOCIATED WITH HYPOTENSION REDUCTION IN SEPTIC INTENSIVE CARE UNIT PATIENTS IN FRANCE
Author(s)
Keuffel E1, Gunnarsson C2, Stevens M3, Davis T3, Maheshwari K4
1Health Finance and Access Initiative, Bryn Mawr, PA, USA, 2Gunnarsson Consulting, Jupiter, FL, USA, 3Edwards Lifesciences, Irvine, CA, USA, 4Center for Perioperative Intelligence, Department of OUTCOMES RESEARCH, Anesthesiology Institute, Cleveland, OH, USA
OBJECTIVES: Emerging data shows an association between hypotension during ICU stay with death and acute kidney injury (AKI). This analysis estimates the cost-savings per ICU patient that can accrue to French hospitals as a result of improved outcomes associated with hypotension reduction in sepsis. METHODS: : In our economic analysis we estimated patient-level costs and the budget impact associated with hypotension reduction in septic ICU patients from the hospital perspective. The reduction in the probabilities of AKI and death were sourced from a prior EMR analysis in which hypotension exposure was defined by time-weighted average mean arterial pressure (TWA-MAP) and cumulative time in hours below 65 mmHg thresholds. Cost savings for each of the separate outcomes in sepsis was estimated from the current literature on cost of French sepsis hospitalization and a multivariate analysis reporting marginal hospitalization costs of AKI. We use the French HICP Index (General) from OECD to update costs. Scenario analyses and Monte Carlo simulations were performed to test the robustness of the model. RESULTS: CONCLUSIONS: In our study, hypotension reduction was shown to reduce hospitalization cost for septic ICU patients with even a 5 unit improvement in hypotension control yielding substantial per patient cost savings to hospitals in France.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PRM41
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine)